Ken Fisher Arcus Biosciences, Inc. Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q2 2025
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 88,163 shares of RCUS stock, worth $852,536. This represents 0.0% of its overall portfolio holdings.
Number of Shares
88,163
Previous 137,638
35.95%
Holding current value
$852,536
Previous $1.08 Million
33.61%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RCUS
# of Institutions
202Shares Held
62.3MCall Options Held
85.7KPut Options Held
86.4K-
Black Rock Inc. New York, NY9.76MShares$94.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.56MShares$63.4 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA5.13MShares$49.6 Million0.28% of portfolio
-
State Street Corp Boston, MA3.7MShares$35.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.87MShares$27.7 Million0.06% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $698M
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...